104 related articles for article (PubMed ID: 12470631)
1. Sinusoidal efflux of taurocholate correlates with the hepatic expression level of Mrp3.
Akita H; Suzuki H; Sugiyama Y
Biochem Biophys Res Commun; 2002 Dec; 299(5):681-7. PubMed ID: 12470631
[TBL] [Abstract][Full Text] [Related]
2. Sinusoidal efflux of taurocholate is enhanced in Mrp2-deficient rat liver.
Akita H; Suzuki H; Sugiyama Y
Pharm Res; 2001 Aug; 18(8):1119-25. PubMed ID: 11587482
[TBL] [Abstract][Full Text] [Related]
3. Efflux mechanism of taurocholate across the rat intestinal basolateral membrane.
Sakamoto S; Suzuki H; Kusuhara H; Sugiyama Y
Mol Pharm; 2006; 3(3):275-81. PubMed ID: 16749859
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment.
Xiong H; Suzuki H; Sugiyama Y; Meier PJ; Pollack GM; Brouwer KL
Drug Metab Dispos; 2002 Sep; 30(9):962-9. PubMed ID: 12167560
[TBL] [Abstract][Full Text] [Related]
5. Characterization of inducible nature of MRP3 in rat liver.
Ogawa K; Suzuki H; Hirohashi T; Ishikawa T; Meier PJ; Hirose K; Akizawa T; Yoshioka M; Sugiyama Y
Am J Physiol Gastrointest Liver Physiol; 2000 Mar; 278(3):G438-46. PubMed ID: 10712264
[TBL] [Abstract][Full Text] [Related]
6. Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides.
Zelcer N; van de Wetering K; de Waart R; Scheffer GL; Marschall HU; Wielinga PR; Kuil A; Kunne C; Smith A; van der Valk M; Wijnholds J; Elferink RO; Borst P
J Hepatol; 2006 Apr; 44(4):768-75. PubMed ID: 16225954
[TBL] [Abstract][Full Text] [Related]
7. The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia.
Keppler D
Drug Metab Dispos; 2014 Apr; 42(4):561-5. PubMed ID: 24459177
[TBL] [Abstract][Full Text] [Related]
8. Compensatory expression of MRP3 in the livers of MRP2-deficient EHBRs is promoted by DHA intake.
Kubo K; Sekine S; Saito M
Biosci Biotechnol Biochem; 2009 Nov; 73(11):2432-8. PubMed ID: 19897918
[TBL] [Abstract][Full Text] [Related]
9. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
[TBL] [Abstract][Full Text] [Related]
10. Time-course activities of Oct1, Mrp3, and cytochrome P450s in cultures of cryopreserved rat hepatocytes.
Jacobsen JK; Jensen B; Skonberg C; Hansen SH; Badolo L
Eur J Pharm Sci; 2011 Oct; 44(3):427-36. PubMed ID: 21925601
[TBL] [Abstract][Full Text] [Related]
11. Involvement of multiple efflux transporters in hepatic disposition of fexofenadine.
Matsushima S; Maeda K; Hayashi H; Debori Y; Schinkel AH; Schuetz JD; Kusuhara H; Sugiyama Y
Mol Pharmacol; 2008 May; 73(5):1474-83. PubMed ID: 18245269
[TBL] [Abstract][Full Text] [Related]
12. Single amino acid substitution of rat MRP2 results in acquired transport activity for taurocholate.
Ito K; Suzuki H; Sugiyama Y
Am J Physiol Gastrointest Liver Physiol; 2001 Oct; 281(4):G1034-43. PubMed ID: 11557524
[TBL] [Abstract][Full Text] [Related]
13. Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites.
Slitt AL; Cherrington NJ; Maher JM; Klaassen CD
Drug Metab Dispos; 2003 Sep; 31(9):1176-86. PubMed ID: 12920174
[TBL] [Abstract][Full Text] [Related]
14. Multiple alterations of canalicular membrane transport activities in rats with CCl(4)-induced hepatic injury.
Song IS; Lee YM; Chung SJ; Shim CK
Drug Metab Dispos; 2003 Apr; 31(4):482-90. PubMed ID: 12642476
[TBL] [Abstract][Full Text] [Related]
15. Hepatic contribution to a marked increase in the plasma concentration of baicalin after oral administration of its aglycone, baicalein, in multidrug resistance-associated protein 2-deficient rat.
Akao T; Sato K; Hanada M
Biol Pharm Bull; 2009 Dec; 32(12):2079-82. PubMed ID: 19952434
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids upregulate taurocholate transport by ileal brush-border membrane.
Nowicki MJ; Shneider BL; Paul JM; Heubi JE
Am J Physiol; 1997 Jul; 273(1 Pt 1):G197-203. PubMed ID: 9252527
[TBL] [Abstract][Full Text] [Related]
17. Adaptive response of the enterohepatic circulation of bile acids to extrahepatic cholestasis.
Dumaswala R; Berkowitz D; Heubi JE
Hepatology; 1996 Mar; 23(3):623-9. PubMed ID: 8617445
[TBL] [Abstract][Full Text] [Related]
18. Compartmental modeling of the hepatic transport of taurocholate in the rat in vivo.
Deroubaix X; Coche T; Depiereux E; Feytmans E
Am J Physiol; 1989 Aug; 257(2 Pt 1):G210-20. PubMed ID: 2764108
[TBL] [Abstract][Full Text] [Related]
19. Quantification of Four Efflux Drug Transporters in Liver and Kidney Across Species Using Targeted Quantitative Proteomics by Isotope Dilution NanoLC-MS/MS.
Fallon JK; Smith PC; Xia CQ; Kim MS
Pharm Res; 2016 Sep; 33(9):2280-8. PubMed ID: 27356525
[TBL] [Abstract][Full Text] [Related]
20. Expression of MRP2 and MRP3 during liver regeneration after 90% partial hepatectomy in rats.
Chang TH; Hakamada K; Toyoki Y; Tsuchida S; Sasaki M
Transplantation; 2004 Jan; 77(1):22-7. PubMed ID: 14724430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
